{"entity":{"type":"insider","cik":"0001787013","url":"/insider/0001787013","json_url":"/insider/0001787013.json","name":"Smith L. Mary","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2021-01-21","last":"2021-10-13","span_basis":"filed_date"},"name_variants":[{"name":"Smith L. Mary","source":"filing","n_filings":4,"first_seen":"2021-01-21","last_seen":"2021-10-13"}],"transactions":[{"id":5344704,"accession":"0001104659-21-125932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-125932","line_url":"/filing/0001104659-21-125932#line-2","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001787013","owner_name":"Smith L. Mary","owner_url":"/insider/0001787013","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.9675,"price_display":"55.97","price_state":"stated","total_value":559675.0,"total_display":"559,675.00","shares_owned_after":167511.0,"shares_owned_after_display":"167,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-13","scope":"insider"},{"id":4673326,"accession":"0001104659-21-092123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-092123","line_url":"/filing/0001104659-21-092123#line-2","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001787013","owner_name":"Smith L. Mary","owner_url":"/insider/0001787013","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":80.8777,"price_display":"80.88","price_state":"stated","total_value":808777.0,"total_display":"808,777.00","shares_owned_after":167511.0,"shares_owned_after_display":"167,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-13","filed_date":"2021-07-14","scope":"insider"},{"id":5459421,"accession":"0001104659-21-049896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-049896","line_url":"/filing/0001104659-21-049896#line-2","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001787013","owner_name":"Smith L. Mary","owner_url":"/insider/0001787013","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":68.0723,"price_display":"68.07","price_state":"stated","total_value":680723.0,"total_display":"680,723.00","shares_owned_after":167511.0,"shares_owned_after_display":"167,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-13","scope":"insider"},{"id":4875682,"accession":"0001104659-21-006328","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-006328","line_url":"/filing/0001104659-21-006328#line-3","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001787013","owner_name":"Smith L. Mary","owner_url":"/insider/0001787013","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":78.7016,"price_display":"78.70","price_state":"stated","total_value":787016.0,"total_display":"787,016.00","shares_owned_after":167511.0,"shares_owned_after_display":"167,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001773427","name":"SpringWorks Therapeutics, Inc.","url":"/issuer/0001773427","role":"Officer (Chief Development Officer)","n_filings":4,"first_seen":"2021-01-21","last_seen":"2021-10-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001787013","retrieved_at":"2026-08-21T11:51:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}